Showing 111 - 120 of 275
A firm's choices in governing itself often reflect not only the characteristics of the particular transaction being governed, but also previous governance choices. In some cases, prior contractual commitments limit the firm's future governance decisions. The authors coin the term "governance...
Persistent link: https://www.econbiz.de/10013153665
Shocks, whether they derive from shifts in demand, supply, regulation, or innovation, can create the need for competitive repositioning by industry participants when they disrupt established sources of competitive advantage. Such situations can therefore create a canonical strategic problem:...
Persistent link: https://www.econbiz.de/10012909137
Persistent link: https://www.econbiz.de/10013270027
Persistent link: https://www.econbiz.de/10013288025
Persistent link: https://www.econbiz.de/10013541903
We examine the relationship between patent protection for pharmaceuticals and investment in development of new drugs. Patent protection has increased around the world as a consequence of the TRIPS Agreement, which specifies minimum levels of intellectual property protection for members of the...
Persistent link: https://www.econbiz.de/10008625935
This paper explores innovation, experimentation, and creativity in the public domain and in the public interest. Researchers in various disciplines have studied public entrepreneurship, but there is little work in management and economics on the nature, incentives, constraints and boundaries of...
Persistent link: https://www.econbiz.de/10008540890
The predominant focus in research on organizations is either on private or public institutions without consistent consideration of their interdependencies. The emphasis in scholarship on private or public interests has strengthened as disciplinary and professional knowledge has deepened:...
Persistent link: https://www.econbiz.de/10005038326
Persistent link: https://www.econbiz.de/10008342823
We examine the relationship between patent protection for pharmaceuticals and investment in development of new drugs. Patent protection has increased around the world as a consequence of the TRIPS Agreement, which specifies minimum levels of intellectual property protection for members of the...
Persistent link: https://www.econbiz.de/10012463181